Veeva Systems Inc Class A Aktie News

Veeva Systems Inc. is the dominant SaaS provider for life sciences, with 80% market share and a highly diversified, resilient customer base. Despite a 40% share price drawdown, VEEV maintains robust fundamentals: 16% revenue growth, >75% gross margins, and a net cash balance covering 20% of its market cap. AI disruption fears are overblown; VEEV's deep domain expertise, integrated platform, and...

Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives PLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on Veeva Link Key People to enhance customer engagement and provide data for AI globally.

Frees sites from duplicate data entry and connects EHR and EDC for higher quality trial data, faster PLEASANTON, Calif., Jan. 29, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva eSource, a new Veeva SiteVault application designed to significantly reduce manual clinical trial processes and increase data quality.

The coming week will put Big Tech earnings and the Federal Reserve firmly in focus, with markets bracing for key signals on growth, inflation, and policy direction.

Veeva Systems Inc. (VEEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

After seeing big-time declines in their share prices recently, three large software stocks just announced significant buyback programs. The combination of falling shares and new buybacks is often a signal that a firm sees its stock as undervalued.

PLEASANTON, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference: J.P.

Partnership to help BioMarin increase speed and efficiency in developing and commercializing innovative therapies PLEASANTON, Calif., and SAN RAFAEL, Calif.